However, in these RCC analyses, the association between CAML size and hazard ratios of several different CAML sizes ranging from 30 μm to 100 μm (Supplementary Fig. 1), found that a CAML size cutoff of 70 μm was the most optimal option for predicting patient disease progression and overall survival (Fig. 2). The gene discussed is CAMLG; the disease is renal cell carcinoma.